<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01218490</url>
  </required_header>
  <id_info>
    <org_study_id>SC 07/12-H</org_study_id>
    <nct_id>NCT01218490</nct_id>
  </id_info>
  <brief_title>Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer</brief_title>
  <acronym>CARACO</acronym>
  <official_title>Pelvic and Aortic-cava Lymphadenectomy Randomized Phase III for Advanced Ovarian Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Cancerologie de l'Ouest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Cancerologie de l'Ouest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is a multicenter randomized trial of superior cleaning compared the absence of dissection
      in stage III patients with optimal surgical resection without retroperitoneal lymph node
      palpable.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>survival with out recurrence</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Ovarian Cancer</condition>
  <arm_group>
    <arm_group_label>lymphadenectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>after surgery of the ovarian cancer, patient will have Pelvis and aortic-cava lymphadenectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no lymphadectomy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>after surgery, the patient will not have pelvic and aortic-cave lymphadenectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ovarian cancer surgery</intervention_name>
    <arm_group_label>lymphadenectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age&gt; 18 years

          -  Karnofsky&gt; 80, or ASA I-II

          -  Primary ovarian adenocarcinoma, or primitive peritoneal

          -  No retroperitoneal lymph node&gt; 2cm (CT; MRI)

          -  Complete surgical staging

          -  Stage III-IV FIGO classification

          -  Indication of systemic chemotherapy before surgery or post surgery

        Exclusion Criteria:

          -  Non Invasive Cancer

          -  non-epithelial or borderline cancer

          -  Pregnancy

          -  Previous pelvic lymphadenectomy or aortic-cava for a disease other than ovarian cancer

          -  Contraindication to Platinum and Paclitaxel

          -  Borderline Ovarian Tumor

          -  tumor recurrence

          -  Incomplete surgery, resectable lesion, Surgery sub optimal (R&gt; 1cm)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clinique Sainte Thérèse</name>
      <address>
        <city>Amiens</city>
        <zip>80000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joël Isapof, MD</last_name>
    </contact>
    <investigator>
      <last_name>Joel Isapof, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Paul Papin</name>
      <address>
        <city>Angers</city>
        <zip>49000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gérard Lorimier, MD</last_name>
      <phone>+330241352700</phone>
    </contact>
    <investigator>
      <last_name>Gérard Lorimier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital</name>
      <address>
        <city>Angers</city>
        <zip>49000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Descamps, MD</last_name>
      <phone>+330241354255</phone>
    </contact>
    <investigator>
      <last_name>Philippe Descamps, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre-François Dupré, MD</last_name>
      <phone>+330298223333</phone>
    </contact>
    <investigator>
      <last_name>Pierre-François Dupré, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Jean Perrin</name>
      <address>
        <city>Clermond Ferrand</city>
        <zip>63011</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillaume Lebouedec, Md</last_name>
      <phone>+33 473278195</phone>
    </contact>
    <investigator>
      <last_name>Guillaume Lebouedec, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre G F Leclerc</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Fraisse, MD</last_name>
      <phone>+33380737508</phone>
    </contact>
    <investigator>
      <last_name>Jean Fraisse, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Léon Berard</name>
      <address>
        <city>Lyon</city>
        <zip>69373</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Hospital</name>
      <address>
        <city>Lyon</city>
        <zip>69437</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrice Mathevet, Md</last_name>
      <phone>+33472117730</phone>
    </contact>
    <investigator>
      <last_name>Patrice Mathevet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Paoli Calmette</name>
      <address>
        <city>Marseille</city>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilles Houvenaeghel, MD</last_name>
      <phone>+33467613015</phone>
    </contact>
    <investigator>
      <last_name>Gilles Houvenaeghel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Val d'Aurelle</name>
      <address>
        <city>Montpellier</city>
        <zip>34298</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philippe Rouanet, MD</last_name>
      <phone>+33467613071</phone>
    </contact>
    <investigator>
      <last_name>Philippe Rouanet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Européen Georges Pompidou</name>
      <address>
        <city>Paris</city>
        <zip>75000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrice Lecurur, MD</last_name>
      <phone>+330156093584</phone>
    </contact>
    <investigator>
      <last_name>Fabrice Lecurur, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>fabrice Lecuru, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Lariboisière</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel Barranger, MD</last_name>
      <phone>+33149956565</phone>
    </contact>
    <investigator>
      <last_name>Emmanuel Barranger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital des Diaconesses</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Villet, MD</last_name>
      <phone>+33144641600</phone>
    </contact>
    <investigator>
      <last_name>Richard Villet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Mutualiste</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Vialard, MD</last_name>
      <phone>+33299857510</phone>
    </contact>
    <investigator>
      <last_name>Jean Vialiard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Leveque, MD</last_name>
      <phone>+33299267171</phone>
    </contact>
    <investigator>
      <last_name>Jean Leveque, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre René Huguenin</name>
      <address>
        <city>Saint Cloud</city>
        <zip>92210</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Serges Lasry, MD</last_name>
      <phone>+33147111515</phone>
    </contact>
    <investigator>
      <last_name>Serge Larsry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Cancerologie de l'Ouest</name>
      <address>
        <city>Saint Herblain</city>
        <zip>44805</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valérie PACTEAU</last_name>
      <phone>+33240679900</phone>
      <phone_ext>9168</phone_ext>
      <email>valerie.pacteau@ico.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Jean Marc Classe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Paul Strauss</name>
      <address>
        <city>Strasbourg</city>
        <zip>67065</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean François Rodier, MD</last_name>
      <phone>+33388252427</phone>
    </contact>
    <investigator>
      <last_name>Jean François Rodier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Claudius Regaud</name>
      <address>
        <city>Toulouse</city>
        <zip>31052</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denis Querleu, MD</last_name>
      <phone>+33561424148</phone>
    </contact>
    <investigator>
      <last_name>Denis Querleu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Bretonneau</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilles Body, MD</last_name>
      <phone>+33247473815</phone>
    </contact>
    <investigator>
      <last_name>Gilles Body, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 8, 2010</study_first_submitted>
  <study_first_submitted_qc>October 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 11, 2010</study_first_posted>
  <last_update_submitted>August 30, 2016</last_update_submitted>
  <last_update_submitted_qc>August 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>surgery</keyword>
  <keyword>ovarian cancer</keyword>
  <keyword>lymphadectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

